Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines

Introduction: Health technology assessment (HTA) in Poland supports reimbursement decisions via the Polish HTA Agency (AOTMiT), whose guidelines were updated in 2016. Methods: We identified key changes introduced by the update and, before guideline publication, analysed discrepancies between AOTMiT...

Full description

Bibliographic Details
Main Authors: Krzysztof Lach, Michal Dziwisz, Cécile Rémuzat, Mondher Toumi
Format: Article
Language:English
Published: MDPI AG 2017-01-01
Series:Journal of Market Access & Health Policy
Subjects:
Online Access:http://dx.doi.org/10.1080/20016689.2017.1355202
_version_ 1797228630472916992
author Krzysztof Lach
Michal Dziwisz
Cécile Rémuzat
Mondher Toumi
author_facet Krzysztof Lach
Michal Dziwisz
Cécile Rémuzat
Mondher Toumi
author_sort Krzysztof Lach
collection DOAJ
description Introduction: Health technology assessment (HTA) in Poland supports reimbursement decisions via the Polish HTA Agency (AOTMiT), whose guidelines were updated in 2016. Methods: We identified key changes introduced by the update and, before guideline publication, analysed discrepancies between AOTMiT assessments and the submitting marketing authorisation holders (MAHs) to elucidate the context of the update. We compared the clarity and detail of the new guidelines versus those of the UK’s National Institute for Health and Care Excellence (NICE). Results: The update specified more precise requirements for items such as indirect comparison or input data for economic modelling. Agency–MAH discrepancies relating to the subjects of the HTA update were found in 14.6% of published documents. The new Polish HTA guidelines were as clear and detailed as NICE’s on topics such as assessing quality of evidence and economic modelling, but were less informative when describing (for example) pairwise meta-analysis. Conclusions: The Polish HTA guidelines update demonstrates lessons learned from internal and external experiences. The new guidelines adhere more closely to UK HTA standards, being clearer and more informative. While the update is expected to reduce Agency–MAH discrepancies, there remain areas for development, such as providing templates to aid HTA submissions.
first_indexed 2024-04-24T14:59:45Z
format Article
id doaj.art-552cc6e499974e95bb9a0f2591145b4d
institution Directory Open Access Journal
issn 2001-6689
language English
last_indexed 2024-04-24T14:59:45Z
publishDate 2017-01-01
publisher MDPI AG
record_format Article
series Journal of Market Access & Health Policy
spelling doaj.art-552cc6e499974e95bb9a0f2591145b4d2024-04-02T15:48:03ZengMDPI AGJournal of Market Access & Health Policy2001-66892017-01-015110.1080/20016689.2017.13552021355202Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelinesKrzysztof Lach0Michal Dziwisz1Cécile Rémuzat2Mondher Toumi3Department of Pricing & Reimbursement and Market Access, Creativ-CeuticalDepartment of Pricing & Reimbursement and Market Access, Creativ-CeuticalDepartment of Pricing & Reimbursement and Market Access, Creativ-CeuticalUniversité de la MéditerranéeIntroduction: Health technology assessment (HTA) in Poland supports reimbursement decisions via the Polish HTA Agency (AOTMiT), whose guidelines were updated in 2016. Methods: We identified key changes introduced by the update and, before guideline publication, analysed discrepancies between AOTMiT assessments and the submitting marketing authorisation holders (MAHs) to elucidate the context of the update. We compared the clarity and detail of the new guidelines versus those of the UK’s National Institute for Health and Care Excellence (NICE). Results: The update specified more precise requirements for items such as indirect comparison or input data for economic modelling. Agency–MAH discrepancies relating to the subjects of the HTA update were found in 14.6% of published documents. The new Polish HTA guidelines were as clear and detailed as NICE’s on topics such as assessing quality of evidence and economic modelling, but were less informative when describing (for example) pairwise meta-analysis. Conclusions: The Polish HTA guidelines update demonstrates lessons learned from internal and external experiences. The new guidelines adhere more closely to UK HTA standards, being clearer and more informative. While the update is expected to reduce Agency–MAH discrepancies, there remain areas for development, such as providing templates to aid HTA submissions.http://dx.doi.org/10.1080/20016689.2017.1355202Health Technology AssessmentguidelinemethodsPoland
spellingShingle Krzysztof Lach
Michal Dziwisz
Cécile Rémuzat
Mondher Toumi
Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
Journal of Market Access & Health Policy
Health Technology Assessment
guideline
methods
Poland
title Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
title_full Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
title_fullStr Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
title_full_unstemmed Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
title_short Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
title_sort towards a more transparent hta process in poland new polish hta methodological guidelines
topic Health Technology Assessment
guideline
methods
Poland
url http://dx.doi.org/10.1080/20016689.2017.1355202
work_keys_str_mv AT krzysztoflach towardsamoretransparenthtaprocessinpolandnewpolishhtamethodologicalguidelines
AT michaldziwisz towardsamoretransparenthtaprocessinpolandnewpolishhtamethodologicalguidelines
AT cecileremuzat towardsamoretransparenthtaprocessinpolandnewpolishhtamethodologicalguidelines
AT mondhertoumi towardsamoretransparenthtaprocessinpolandnewpolishhtamethodologicalguidelines